Why Alvotech (ALVO) Stock Is Rising
As of 2026-09-24, Alvotech (ALVO) has a next-year EPS growth estimate of 1766.86%. Featured in our EPS revision report on 2026-09-24.
Why ALVO Stock Is Rising
- +EPS Estimate Upgraded: Analysts raised Alvotech's next-year EPS growth estimate from 1620.02% to 1766.86% on 2026-09-16.
- ·Current-Year Growth: Projected at 86.07%, supporting the forward estimate revision.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 1766.86%
- EPS growth this year
- 86.07%
- EPS next quarter (est)
- -$0.03
- Last price
- $5.94
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-09-24 | 1766.86% | 86.07% | -$0.03 | $5.94 |
| 2026-09-23 | 1766.86% | 86.07% | -$0.03 | $5.81 |
| 2026-09-22 | 1766.86% | 86.07% | -$0.03 | $5.84 |
| 2026-09-21 | 1766.86% | 86.07% | -$0.03 | $5.88 |
| 2026-09-20 | 1766.86% | 86.07% | -$0.03 | $5.87 |
| 2026-09-18 | 1766.86% | 86.07% | -$0.03 | $5.87 |
| 2026-09-17 | 1766.86% | 86.07% | -$0.03 | $5.34 |
| 2026-09-16 | 1766.86% | 86.07% | -$0.03 | $5.10 |
| 2026-09-15 | 1620.02% | 85.07% | -$0.02 | $5.02 |
| 2026-09-14 | 1620.02% | 85.07% | -$0.02 | $5.05 |
| 2026-09-13 | 1620.02% | 85.07% | -$0.02 | $5.29 |
| 2026-09-11 | 1620.02% | 85.07% | -$0.02 | $5.29 |
| 2026-09-10 | 1620.02% | 85.07% | -$0.02 | $5.24 |
| 2026-09-09 | 1620.02% | 85.07% | -$0.02 | $5.21 |
| 2026-09-08 | 1620.02% | 85.07% | -$0.02 | $5.19 |
| 2026-09-07 | 1620.02% | 85.07% | -$0.02 | $5.32 |
| 2026-09-06 | 1620.02% | 85.07% | -$0.02 | $5.32 |
| 2026-09-04 | 1620.02% | 85.07% | -$0.02 | $5.32 |
| 2026-09-03 | 1620.02% | 85.07% | -$0.02 | $5.38 |
| 2026-09-02 | 1620.02% | 85.07% | -$0.02 | $5.34 |
| 2026-09-01 | 1620.02% | 85.07% | -$0.02 | $5.24 |
| 2026-08-31 | 1620.02% | 85.07% | -$0.02 | $5.19 |
| 2026-08-30 | 1620.02% | 85.07% | -$0.02 | $4.95 |
| 2026-08-29 | 1620.02% | 85.07% | -$0.02 | $4.95 |
| 2026-08-28 | 1620.02% | 85.07% | -$0.02 | $4.95 |
| 2026-08-27 | 1620.02% | 85.07% | -$0.02 | $4.88 |
| 2026-08-26 | 1620.02% | 85.07% | -$0.02 | $4.91 |
| 2026-08-25 | 1620.02% | 85.07% | -$0.02 | $5.05 |
| 2026-08-24 | 1620.02% | 85.07% | -$0.02 | $5.25 |
| 2026-08-23 | 1075.52% | 77.23% | -$0.03 | $4.43 |
Reports Featuring ALVO
Recent News
- ALVO Stock Jumps On Double Upgrade Why Barclays Sees A 59% UpsideStocktwits
- Alvotech Shares Rise 5.6% After Barclays Upgrades Rating and Doubles Price TargetInvestorsHub
- BofA starts bullish Alvotech coverage on biosimilar launch cycleInvesting.com
- Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian MarketsGlobeNewswire
- Alvotech Q2 2026 Earnings Call SummaryMoby
Screen Performance
Aggregate stats across all 2048 tickers our top-EPS-revision screen has flagged over the past 176 days.
- Median return since detection
- +0.0%
- % of tickers in the green
- 50%
- Median return on winners
- +22.8%
- Large revisions captured
- 1763
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did Alvotech (ALVO) stock go up recently?▾
Alvotech (ALVO) stock has risen following an analyst upgrade of its next-year EPS growth estimate from 1620.02% to 1766.86% on 2026-09-16. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is Alvotech's next-year EPS growth estimate?▾
As of 2026-09-24, Alvotech (ALVO) has a next-year EPS growth estimate of 1766.86%, based on analyst consensus.
When was the latest EPS estimate revision for ALVO?▾
The most recent revision occurred on 2026-09-16, when analysts adjusted the next-year EPS growth estimate from 1620.02% to 1766.86%.
What sector and industry does Alvotech belong to?▾
Alvotech operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ALVO appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Alvotech (ALVO) appears here because it was detected by our daily top-EPS-revision-performer screen.